GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » YoY EPS Growth

Hamlet BioPharma AB publ (XSAT:HAMLET B) YoY EPS Growth : 28.57% (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Hamlet BioPharma AB publ's YoY EPS Growth for the quarter that ended in Mar. 2025 was 28.57%.

Hamlet BioPharma AB publ's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was kr-0.07.


Hamlet BioPharma AB publ YoY EPS Growth Historical Data

The historical data trend for Hamlet BioPharma AB publ's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ YoY EPS Growth Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,059.06 96.27 -1,922.97 87.84 -36.81

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -96.00 -155.56 12.86 -10.96 28.57

Hamlet BioPharma AB publ YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Hamlet BioPharma AB publ's YoY EPS Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EPS Growth (A: Jun. 2024 )
=(Earnings per Share (Diluted) (A: Jun. 2024 )-Earnings per Share (Diluted) (A: Jun. 2023 ))/ | Earnings per Share (Diluted) (A: Jun. 2023 ) |
=(-0.249--0.182)/ | -0.182 |
=-36.81 %

Hamlet BioPharma AB publ's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EPS Growth (Q: Mar. 2025 )
=(Earnings per Share (Diluted) (Q: Mar. 2025 )-Earnings per Share (Diluted) (Q: Mar. 2024 )) / | Earnings per Share (Diluted) (Q: Mar. 2024 )) |
=(-0.07--0.098)/ | -0.098 |
=28.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamlet BioPharma AB publ YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines